Transcatheter arterial procedures in the treatment of patients with hepatocellular carcinoma: A review of literature

Critical Reviews in Oncology/Hematology

Volumn 46, Issue 3, 2003, Pages 285-295

  De Maio, Ermelinda ^a   Fiore, Francesco ^b   Daniele, Bruno ^a   D'Angelo, Roberto ^b   Perrone, Francesco ^b   Barletta, Emiddio ^a   Iaffaioli, Rosario Vincenzo ^a   Pignata, Sandro ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Transcatheter arterial procedures

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETHYL CELLULOSE; FLUOROURACIL; GELATIN SPONGE; GELFOAM; IODINATED POPPYSEED OIL; MITOMYCIN C; POLYVINYL ALCOHOL; TAMOXIFEN;

ABDOMINAL PAIN; ANTINEOPLASTIC ACTIVITY; APPETITE DISORDER; ARTIFICIAL EMBOLISM; ASCITES; BLEEDING; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CATHETER; DRUG CLEARANCE; DRUG PENETRATION; ESOPHAGUS VARICES; HUMAN; INJECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER TOXICITY; LIVER TRANSPLANTATION; MEDICAL DOCUMENTATION; MEDLINE; METASTASIS; MULTIPLE CANCER; PALLIATIVE THERAPY; PATIENT; PATIENT SELECTION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE INFECTION; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVASCULARIZATION; REVIEW; SCORING SYSTEM; STANDARDIZATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR BLOOD FLOW; TUMOR NECROSIS; TUMOR VOLUME;

EID: 0038182096     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(02)00175-0     Document Type: Review

References (63)

1. Flickinger J.C., Carr B.I., Lotze M.T. Hepatobiliary cancers. De Vita V.T. Jr., Hellmann S., Rosemberg S.A. Principles and practice of oncology. 5th ed. 1997;1087-1114 Lippincott-Raven, Philadelphia, PA.
2. Livraghi T. Percutaneous ethanol injection of hepatocellular carcinoma: survival after 3 years in 70 patients. Ital. J. Gastroenterol. 24:1992;72-74.
3. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 28:(3):1998;751-755.
4. Damascelli B., Garbagnati F., Marchiano A., et al. Embolization and chemoembolization for hepatocellular carcinoma. Ital. J. Gastroenterol. 24:1992;103-104.
5. Simonetti R.G., Liberati A., Angiolini C. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann. Oncol. 8:1997;117-136.
6. Takayasu K., Suzuki M., Uesaka K., et al. Hepatic artery embolization for inoperable hepatocellular carcinoma: prognosis and risk factors. Cancer Chemother. Pharmacol. 23:(Suppl):1989;S123-S125.
7. Ikeda K., Kumada H., Saitoh S., Arase Y., et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer. 68:1991;2150-2154.
8. Alvarez R., Banares R., Echenagusia A., et al. Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma. Gastroenterol. Hepatol. 23:(4):2000;153-158.
9. Vogl T.J., Trapp M., Schroeder H., et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-result from a liver transplantation center. Radiology. 214:(2):2000;349-357.
10. Mondazzi L., Bottelli R., Brambilla G., et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology. 19:(5):1994;1115-1123.
11. Savastano S., Miotto D., Casarrubea G., et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J. Clin. Gastroenterol. 28:(4):1999;334-340.
12. Yamamoto K., Masuzawa M., Kato M., et al. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Cancer Chemother. Pharmacol. 31:(Suppl 1):1992;S77-S81.
13. Taniguchi K., Nakata K., Kato Y., et al. Treatment of hepatocellular carcinoma with Transcatheter arterial embolization. Cancer. 73:(5):1994;1341-1345.
14. Yamashita Y., Takahashi M., Koga Y., et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer. 67:1991;385-391.
15. Shijo H., Okazaki M., Higashihara H., et al. Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization. Am. J. Gastoenterol. 87:(9):1992;1154-1159.
16. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer. 56:1985;918-928.
17. Llado L., Virgili J., Figueras J., et al. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer. 88:(1):2000;50-57.
18. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60:1973;646-664.
19. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology. 31:2000;840-845.
20. Chung J.W., Park J.H., Han J.K. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 198:1996;33-40.
21. Bruix J., Castells A., Montanya X., et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. Hepatology. 20:1994;643-650.
22. Ikeda K., Kumada H., Saitoh S., Arase Y., et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer. 68:1991;2150-2154.
23. Groupe d'Etude et de treatment du carcinome hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-61.
24. Caturelli E., Siena D.A., Fusilli S., et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology. 215:2000;123-128.
25. Bronowicki J.P., Vetter D., Dumas F. Transcatheter oily chemoembolization for hepatocellular carcinoma: 4 year study of 127 French patients. Cancer. 74:1994;16-24.
26. Yamada K., Sato M., Katawaba M., et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 148:1983;397-401.
27. Bismuth H., Morino M., Sherlock D., et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am. J. Surg. 163:1992;387-394.
28. Nakamura H., Mitani T., Murakami T., et al. Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma. Cancer Chemother. Pharmacol. 33:1994;S89-S92.
29. Bruix J., Llovet L., Castels A., et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: result of a randomized controlled trial in a single institution. Hepatology. 27:(6):1998;1578-1583.
30. Okada S. Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues. Hepatology. 27:(6):1998;1743-1744.
31. Levin B., Christopher A. Therapy of unresectable hepatocellular carcinoma. N. Engl. J. Med. 32:(19):1995;1294-1296.
32. Pelletier G., Roche A., Ink O., et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J. Hepatology. 11:1990;181-184.
33. Madden M.V., Krige J.E.J., Bailey S., et al. Randomised trial of targeted chemotherapy with lipodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut. 34:1993;1598-1600.
34. Lin D.Y. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma. A randomized controlled trial. Gastroenterology. 94:(2):1988;453-456.
35. Rougier P., Pelletier M., Ducreux F., et al. Unresectable hepatocellular carcinoma: lack of efficacy of lipiodol chemoembolization. Final results of a multicenter randomized trial. Proc. ASCO. 16:2000;279.
36. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 359:2002;1734-1739.
37. Matsui O., Kadoya M., Yoshikawa J., Gabata T. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology. 188:1993;79-83.
38. Murakami R., Yoshimatsu S., Yamashita Y. Transcatheter hepatic subsegmental arterial chemoembilization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence. Acta Radiol. 35:(6):1994;576-580.
39. Arii S., Yamaoka Y., Futagawa S., et al. Result of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospecitve and nationwide survey in Japan. Hepatology. 32:(6):2000;1224-1229.
40. Ye-Quin Yu, Xu D.B., Zhou X.D., et al. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer. 71:1993;61-65.
41. Hwang T.L., Chen M.F., Lee T.Y., et al. Resection of hepatocellular carcinoma after transcatheter embolization: reevaluation of advantage and disadvantage of preoperative embolization. Arch. Surg. 122:1987;756-759.
42. Wu C.C., Ho Y.Z., Ho W.L., et al. Preoperative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology. 45:(24):1998;1950-1954.
43. Gerunda G.E., Neri D., Merenda R., et al. Role of transcatheter chemoembolization before liver resection for hepatocellular carcinoma. Liver Transpl. 6:(5):2000;619-626.
44. Majno P.E., Adam R., Bismuth H., et al. Influence of preoperative transarterial lipiodol chemoembolization in resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann. Surg. 226:(6):1997;688-703.
45. Imaoka S., Sasaki Y., Shibata T., et al. A preoperative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for HCC. Cancer Chem. Pharm. 23:(Suppl):1989;S126-S128.
46. Uchida M., Kohno H., Kubota H., et al. Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J. Surg. 20:(3):1996;326-331.
47. Richard M.H., Silberzweig J.E., Harold A.M., et al. Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma. Radiology. 214:(3):2000;775-779.
48. Oldhafer K.J., Chavan A., Fruhauf N.R., et al. Arterial chemoembolization before liver transplantation in patients with HCC; marked tumor necrosis, but no survival benefit? J. Hepatology. 29:(6):1998;953-959.
49. Tanaka K., Nakamura S., Numata K., et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology. 185:1992;457-460.
50. Koda M., Okanoto K., Kato S. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma. Hepatogastroenterology. 41:1994;25-29.
51. Bartolozzi C., Lencioni R., Caramella D., et al. Treatment of large HCC: transcatheter arterial chembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology. 197:(3):1995;812-818.
52. Allaiger H.P., Deibert P., Olschewski M., et al. Survival benefit of patients with inoperable hepatocellular carcinoma treated by combination of transarterial chemoembolization and percutaneous ethanol injection-a single center analysis including 132 patients. Int. J. Cancer. 79:(6):1998;601-605.
53. Kawai S., Okamura J., Ogamowa M., et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). Cancer Chemother. Pharmacol. 31:(Suppl 1):1992;S1-S6.
54. Takayasu K., Shima Y., Muramatsu Y., et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology. 162:1987;345-351.
55. Chang J.M., Tzeng W.S., Pan H.B., et al. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer. 74:(9):1994;2449-2453.
56. Watanabe S., Nishioka M., Ohta Y., et al. Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cancer Chemother. Pharm. 31:(Suppl I):1992;S20-S24.
57. Okamura J., Kawai S., Ogawa M., et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of l-TAE with farmorubicin and L-TAE with adryamicin (second cooperative study). Cancer Chemother. Pharm. 31:(Suppl I):1992;S20-S24.
58. Kasugai H., Kojima J., Okuda S., et al. Treatment pf hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology. 97:1989;965-971.
59. Sasaki Y., Imaoka S., Kasugai H. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin and gelatine sponge. Cancer. 60:1987;1194-1203.
60. Audisio R.A., Doci R., Mazzaferro V., et al. Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. Cancer. 66:1990;228-236.
61. Makuuchi M., Sukigara M., Mori T., et al. Bile duct necrosis: complication of transcatheter arterial embolization. Radiology. 156:1985;331-334.
62. Nakao N., Uchida H., Kamino K., et al. Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother. Pharmacol. 31:(Suppl):1992;S72-S76.
63. Ernst O., Sergent G., Mizrahi D., et al. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. Am. J. Roentgenol. 172:(1):1999;59-64.